Due to fraudulence and misconduct in research, advances in Alzheimer’s Disease treatments have been hindered. Read More.
Other Posts
DCD and Clinical Ethics
Donation after circulatory death (DCD) now accounts for nearly half of deceased organ donations in the United States, reflecting advances in preservation techniques that help address organ shortages. Unlike brain death donation, DCD occurs after [...]
AI and the Biological Weapons Convention
Ensuring compliance with the Biological Weapons Convention (BWC) has long posed verification challenges due to the absence of a formal monitoring mechanism. An article in National Defense Magazine discusses how artificial intelligence (AI) could assist [...]
The UK’s First Birth After Uterus Transplant
A woman in the United Kingdom has become the first in the country to give birth after undergoing a womb transplant from a deceased donor, marking a significant development in reproductive medicine. Unlike most organ [...]
Hospitals Fighting Measles Confront a Challenge: Few Doctors Have Seen It Before
At Mission Hospital, in Asheville, North Carolina, two seven-year-old boys were admitted with a case of measles. However, the cases were not diagnosed right away, and exposed hospital staff and patients to the virus. This [...]
The Past is Prologue: Why Bioethics Matters More Than Ever
Bioethics is crucial today because it's rooted in the harsh lessons of history, particularly the atrocities committed during World War II, like the Nazi human experiments. The Nuremberg Code was established as a response, emphasizing [...]
Selling Plasma to Stay Afloat
There are a growing number of middle class Americans that are selling their plasma, as financial strain threatens their ability to cover basic expenses. Companies frame giving plasma as an altruistic donation, with the compensation [...]
